Release from Th1-type immune tolerance in spleen and enhanced production of IL-5 in Peyer’s patch by cholera toxin B induce the glomerular deposition of IgA-Reference-Cited by-同舟云学术

Release from Th1-type immune tolerance in spleen and enhanced production of IL-5 in Peyer’s patch by cholera toxin B induce the glomerular deposition of IgA

Published:2016-04 Issue:4 Volume:221 Page:577-585
ISSN:0171-2985
Container-title:Immunobiology
language:en
Short-container-title:Immunobiology

Author:

Yamanaka Takahiro,Tamauchi Hidekazu,Suzuki Yusuke,Suzuki Hitoshi,Horikoshi Satoshi,Terashima Masazumi,Iwabuchi Kazuya,Habu Sonoko,Okumura Ko,Tomino Yasuhiko

Funder

JSPS KAKENHI

Publisher

Elsevier BV

Subject

Hematology,Immunology,Immunology and Allergy

Reference34 articles.

1. Intercapillary deposits of IgA-IgG;Berger;J. Urol. Nephrol. (Paris),1968

2. Transforming growth factor- beta regulates production of proteoglycans by mesangial cells;Border;Kidney Int.,1990

3. Roles of TGF-beta1 and poptosis in the progerssion of glomerulosclerosis in human IgA nephropathy;Chihara;Clin. Nephrol.,2006

4. The glycosylation of IgA produced by murine B cells is altered by Th2 cytokines;Chintalacharuvu;J. Immunol.,1997

5. T cell cytokines determine the severity of experimental IgA nephropathy by regulating IgA glycosylation;Chintalacharuvu;Clin. Exp. Immunol.,2001

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IgA nephropathy associated with Crohn's disease;World Journal of Methodology;2023-06-20

2. The upregulation of miR-98-5p affects the glycosylation of IgA1 through cytokines in IgA nephropathy;International Immunopharmacology;2020-05

3. T lymphocytes in IgA nephropathy (Review);Experimental and Therapeutic Medicine;2020-04-22

4. Immunosuppressive effect of artemisinin and hydroxychloroquine combination therapy on IgA nephropathy via regulating the differentiation of CD4+ T cell subsets in rats;International Immunopharmacology;2019-05

5. Prediction of Drug Positioning for Quan-Du-Zhong Capsules Against Hypertensive Nephropathy Based on the Robustness of Disease Network;Frontiers in Pharmacology;2019-02-12